Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hydroxychloroquine versus standard drug therapy for brucellosis
IRCT201406299014N37Phase 2Unknown
- Sponsor
- Hamadan University of Medical Sciences
- Start
- Jul 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of hydroxychloroquine in brucellosis (2 arms), sponsored by Hamadan University of Medical Sciences. Status: unknown.
02
Drugs
hydroxychloroquine
03
Conditions
brucellosis
Beyond the preview
Go deeper on IRCT201406299014N37.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT201406299014N37.